Overexpression of cyclin A has been associated with worse prognosis for breast cancer in several studies (Bukholm et al, 2001; Michalides et al, 2002; Michels et al, 2002), but the results have not been consistent (Kuhling et al, 2003; Rudolph et al, 2003). Here, CCNA2 is linked to breast cancer.